The Role of Cardiac Side Population Cells in Cardiac Regeneration
Related Experiment Video
Updated: Mar 14, 2026
Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
Published on: January 7, 2019
Amritha Yellamilli1, Jop H van Berlo2
1Stem Cell Institute, University of MinnesotaMinneapolis, MN, USA; Lillehei Heart Institute, University of MinnesotaMinneapolis, MN, USA; Department of Integrative Biology and Physiology, University of MinnesotaMinneapolis, MN, USA.
Insights
Cardiac side population cells (cSPCs) show promise for heart regeneration. These progenitor cells can replace lost heart cells and improve cardiac function after injury, offering new therapeutic strategies.
Area of Science:
- Cardiovascular biology
- Regenerative medicine
- Stem cell therapy
Background:
- The adult heart has limited regenerative capacity, leading to cell loss in heart failure.
- Identifying strategies to replace lost cardiomyocytes is crucial for treating heart failure.
- Cardiac progenitor cells offer potential for cardiac repair and regeneration.
Purpose of the Study:
- To review the properties of cardiac progenitor cells, specifically cardiac side population cells (cSPCs).
- To discuss the therapeutic potential of cSPCs in enhancing cardiac regeneration.
- To highlight cSPCs as promising targets for novel regenerative therapies.
Main Methods:
- Literature review of studies on cardiac progenitor cells and cSPCs.
- Analysis of cSPC differentiation capabilities and activation in response to injury.
- Evaluation of outcomes from cSPC transplantation in cardiac injury models.
Main Results:
- Cardiac side population cells (cSPCs) are the first identified cardiac progenitor cells in the adult heart.
- cSPCs possess self-renewing and multipotent properties, differentiating into cardiomyocytes, endothelial cells, smooth muscle cells, and fibroblasts.
- Activation of cSPCs post-cardiac injury and improved cardiac function following cSPC transplantation have been observed.
Conclusions:
- Cardiac side population cells demonstrate significant potential as a target for regenerative medicine.
- Therapeutic strategies utilizing cSPCs could address cardiomyocyte loss in heart failure.
- Further research into cSPC properties and applications holds promise for advancing cardiac repair.
Abstract:
The heart has a limited ability to regenerate. It is important to identify therapeutic strategies that enhance cardiac regeneration in order to replace cardiomyocytes lost during the progression of heart failure. Cardiac progenitor cells are interesting targets for new regenerative therapies because they are self-renewing, multipotent cells located in the heart. Cardiac side population cells (cSPCs), the first cardiac progenitor cells identified in the adult heart, have the ability to differentiate into cardiomyocytes, endothelial cells, smooth muscle cells, and fibroblasts. They become activated in response to cardiac injury and transplantation of cSPCs into the injured heart improves cardiac function. In this review, we will discuss the current literature on the progenitor cell properties and therapeutic potential of cSPCs. This body of work demonstrates the great promise cSPCs hold as targets for new regenerative strategies.
